Stockreport

ANI Pharmaceuticals completes purchase of Alimera Sciences [Seeking Alpha]

Perella Weinberg Partners - Class A  (PWP) 
PDF Under the terms of the merger agreement, ANI acquired all of the outstanding shares of Alimera for $5.50 per share, according to a statement on Monday. Alimera investor [Read more]